SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

HERRERA, Cristina et al. In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz [online]. 2009, vol.104, n.7, pp.980-985. ISSN 0074-0276.

    Cassels BK, Herreros S, Ibanez C, Rezende MC, Sebastian C, Sepúlveda S 1982. Synthesis of antitumoral 1-aryl-2-nitroalkenes. An Asoc Quim Argent 70: 283-288. [ Links ]

    Cerecetto H, Di Maio R, González M, Risso M, Sagrera G, Seoane G, Denicola A, Peluffo G, Quijano C, Stoppani AOM, Paulino M, Olea-Azar C, Basombrio MA 2000. Synthesis and antitrypanosomal evaluation of E-isomers of 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives, structure-activity relationships. Eur J Med Chem 35: 343-350. [ Links ]

    Cerecetto H, González M 2008. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds. Mini Rev Med Chem 8: 1355-1383. [ Links ]

    Coura JR, De Castro SL 2002. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3-24. [ Links ]

    Darsaud A, Chevrier C, Bourdon L, Dumas M, Buguet A, Bouteille B 2004. Megazol combined with suramin improves a new diagnosis index of the early meningo-encephalitic phase of experimental African trypanosomiasis. Trop Med Int Health 9: 83-91. [ Links ]

    De Oliveira RB, Passos APF, Alves RO, Romanha AJ, Prado MAF, Souza FJ, Alves RJ 2003. In vitro evaluation of the activity of aromatic nitrocompounds against Trypanosoma cruzi. Mem Inst Oswaldo Cruz 98: 141-144. [ Links ]

    De Oliveira RB, Vaz ABM, Alves RO, Liarte DB, Donnici CL, Romanha AJ, Zani CL 2006. Arylfurans as potential Trypanosoma cruzi trypanothione reductase inhibitors. Mem Inst Oswaldo Cruz 101: 169-173. [ Links ]

    De Souza AO, Hemerly FP, Melo PS, Machado GMC, Miranda CC, Santa-Rita RM, Haun M, León LL, Sato DN, De Castro SL, Durán N 2002. 3-[42 -Bromo-(1,12 -biphenyl)-4-yl]-N,N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity and leishmanicidal, trypanocidal and antimycobacterial activities. J Antimicrob Chemother 50: 629-637. [ Links ]

    Dias JPC, Silveira AC, Schofield CJ 2002. The impact of Chagas disease control in Latin America - A review. Mem Inst Oswaldo Cruz 97: 603-612. [ Links ]

    Docampo R 2001. Recent developments in the chemotherapy of Chagas disease. Curr Pharm Des 7: 1157-1164. [ Links ]

    Enanga B, Ariyanayagam MR, Stewart ML, Barrett MP 2003. Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage. Antimicrob Agents Chemother 47: 3368-3370. [ Links ]

    González JL, Stephens CE, Wenzler T, Brun R, Tanious FA, Wilson WD, Barszcz T, Werbovetz KA, Boykin DW 2007. Synthesis and antiparasitic evaluation of bis-2,5-[4-guanidinophenyl]thiophenes. Eur J Med Chem 42: 552-557. [ Links ]

    Henderson GB, Ulrich P, Fairlambt AH, Rosenberg I, Pereira M, Sela M, Cerami A 1988. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Biochemistry 85: 5374-5378. [ Links ]

    Hyde TP, Dvorak JA 1973. Trypanosoma cruzi: interaction with vertebrate cells in vitro. Quantitative analysis of the penetration phase. Exp Parasitol 34: 284-294. [ Links ]

    Kamnaing P, Tsopmo A, Tanifum EA, Tchuendem MHK, Tane P, Ayafor JF, Sterner O, Rattendi D, Iwu MM, Schuster B, Bacchi C 2003. Trypanocidal diarylheptanoids from Aframomun letestulnum. J Nat Prod 66: 364-367. [ Links ]

    Kirchhoff LV 2005. Trypanosomiasis. In: DL Kasper, AS Fauci, DL Longo, E Braunwald, SL Hauser, JL Jameson. Harrison's principles of internal medicine, 16th edition, Mac Graw Hill, New York, p. 1373-1377. [ Links ]

    Le-Senne A, Muelas S, Fernando C, Escario JA, Gómez A 2002. Biological characterization of a β-galactosidase expressing clone of Trypanosoma cruzi CL strain. Mem Inst Oswaldo Cruz 97: 1101-1105. [ Links ]

    Mady C, Ianni BM, de Souza JL 2008. Benznidazole and Chagas disease: can an old drug be the answer to an old problem? Expert Opin Investig Drugs 17: 1427-1433. [ Links ]

    Maya JD, Bollo S, Nuñez-Vergara LJ, Squella JA, Repetto Y, Morillo A, Perie J, Chauviere G 2003. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem Pharmacol 65: 999-1006. [ Links ]

    Maya JD, Cassels BK, Iturriaga-Vásquez P, Ferreira J, Faúndez M, Galanti N, Ferreira A, Morello A 2007. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol 146: 601-620. [ Links ]

    Mecca MM de, Bartel LC, Castro CR de, Castro JA 2008. Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to nifurtimox-induced cardiac effects. Mem Inst Oswaldo Cruz 103: 549-553. [ Links ]

    Moncayo A 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98: 577-591. [ Links ]

    Mosmann T 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63. [ Links ]

    Muelas-Serrano S, Le-Senne A, Fernández-Portillo C, Nogal JJ, Ochoa C, Gómez-Barrio A 2002. In vitro and in vivo anti-Trypanosoma cruzi activity of a novel nitro-derivative. Mem Inst Oswaldo Cruz 97: 553-557. [ Links ]

    Nesslany F, Brugier S, Mouries MA, Le Curieux F, Marzin D 2004. In vitro and in vivo chromosomal aberrations induced by megazol. Mutat Res Genet Toxicol Environ Mutagen 560: 147-158. [ Links ]

    Olea-Azar C, Rigol C, Mendizabal F, Morello A, Maya JD, Repetto Y, Aguirre G, Cerecetto H, Di Maio R, González M, Porcal W 2003. ESR spin trapping studies of free radicals generated from nitrofuran derivative analogues of nifurtimox by electrochemical and Trypanosoma cruzi reduction. Free Radic Res 37: 993-1001. [ Links ]

    Petray PB, Morilla MJ, Corral RS, Romero EL 2004. In vitro activity of etanidazole against the protozoan parasite Trypanosoma cruzi. Mem Inst Oswaldo Cruz 99: 233-235. [ Links ]

    Pozas R, Carballo J, Castrob C, Rubiob J 2005. Synthesis and in vitro antitrypanosomal activity of novel nifurtimox analogues. Bioorg Med Chem Lett 15: 1417-1421. [ Links ]

    Quesada A, Arguello J, Squella JA, JL Wardell, Lowd JN, Glidewell C 2006. Hydrogen-bonded supramolecular structures of three related 4-(5-nitro-2-furyl)-1,4-dihydropyridines. Acta Crystallogr C62: 8-12. [ Links ]

    Rodríguez AJ 2005. Nuevas perspectivas en el manejo terapéutico de la enfermedad de Chagas. Rev Peru Med Exp Salud Publica 22: 123-133. [ Links ]

    Sánchez G, Cuellar D, Zulantay I, Gajardo M, González-Martin G 2002. Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles. Biol Res 35: 39-45. [ Links ]

    Stewart M, Jiménez G, Baliani A, Klenke B, Brun R, Brock JM, Gilbert IH, Barrett MP 2004. Trypanocidal activity of melamine-based nitroheterocycles. Antimicrob Agents Chemother 48: 1733-1738. [ Links ]

    Stoppani AOM 1999. Quimioterapia de la Enfermedad de Chagas. Medicina 59: 147-165. [ Links ]

    Urbina JA 1999. Parasitological cure of Chagas disease: is it possible? Is it relevant? Mem Inst Oswaldo Cruz 94 (Suppl. I): 349-355. [ Links ]

    Urbina JA 2002. Chemotherapy of Chagas disease. Curr Pharm Des 8: 287-295. [ Links ]

    Urbina JA 2005. Nuevos avances en el desarrollo del tratamiento etiológico de la enfermedad de Chagas. Mesas de Debate, OMS/OPS, Buenos Aires, 9 pp. [ Links ]

    Urbina JA, Docampo R 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19: 495-501. [ Links ]

    Vallejos G, Fierro A, Rezende MC, Sepúlveda-Boza S, Reyes-Parada M 2005. Heteroarylisopropylamines as MAO inhibitors. Bioorg Med Chem 13: 4450-4457. [ Links ]